Which medicines are covered The PAP only covers a specific list of Novo Nordisk registered trademark medicines, which currently includes certain GLP-1 medications (Ozempic, Rybelsus and Xultophy), insulin products (Fiasp, Novolin R, Novolin N and Novolin 70/30, NovoLog Vial, NovoLog PenFill and Flexpen, NovoLog Mix, Tresiba), devices (Novopen, NovoFine), and other selected specialty therapies
With further research, GL may potentially be a future neoadjuvant option in melanoma
Role of glutathione S-transferases in protection against lipid peroxidation
Certain probiotic strains help rebalance the gut and improve digestion, which could support weight loss efforts
10.1210/jcem-71-5-1215 24
musculoskeletal disease (rheumatoid arthritis, psoriatic arthritis)